期刊文献+

早产儿肺透明膜病并发支气管肺发育不良的高危因素及预防 被引量:10

Analysis of risk factors and prevention of bronchopulmonary dysplasia in premature infant with hyaline membrane disease
下载PDF
导出
摘要 目的了解支气管肺发育不良(BPD)的临床特征及高危因素,为BPD的预防和治疗提供借鉴。方法选2007年1月至2010年1月新生儿重症监护室早产儿肺透明膜病(HMD)114例,根据有无支气管肺发育不良(BPD)分为2组,对两组的临床资料进行回顾性分析。结果 114例患儿中22例发生BPD(19.3%),为BPD组,其中17例治愈出院,5例放弃治疗死亡;92例未发生BPD,为对照组。BPD组的胎龄、出生体质量及1分钟Apgar评分均低于对照组,而机械通气时间、吸氧时间、住院时间、感染率均长于或高于对照组,各种其他并发症如严重视网膜病、动脉导管未闭、早产儿脑积水发生率均明显高于对照组。两组在重度HMD发生率及肺表面活性物质(PS)使用上差异无统计学意义。结论 BPD的发生与胎龄、出生体质量、感染、机械通气时间、吸氧时间及动脉导管未闭等相关,故积极预防早产、尽可能降低机械通气及吸氧时间、积极控制感染和关闭动脉导管,可能会降低BPD的发生。
出处 《临床儿科杂志》 CAS CSCD 北大核心 2010年第12期1162-1165,共4页 Journal of Clinical Pediatrics
关键词 肺透明膜病 支气管肺发育不良 早产儿 危险因素 hyaline membrane disease bronchopulmonary dysplasia premature infant risk factors
  • 相关文献

参考文献10

  • 1Monte LF, Silva Filho LV, Miyoshi MH, et al. Bronchopulmonary dysplasia [J]. J Pediatr(Rio J),2005,81 (2): 99-110.
  • 2Ballard HO, Anstead MI, Shook LA. Azithromycin in the extremely low birth weight infant for the prevention of bronchopulmonary dysplasia: a pilot study [J]. Respir Res, 2007,8( 1 ) :41.
  • 3Coalson JJ. Pathology of new bronchopulmonary dysplasia [J]. Semin Noenatol,2003,8(1 ) :73-81.
  • 4Geary C, Caskey M, Fonseca R, et al. Decreased incidence of bronchopulmonary dysplasia after early management changes, including surfactant and nasal continuous positive airway pressure treatment at delivery, lowered oxygen saturation goals, and early amino acid administration: a historical cohort study [J]. Pediatrics, 2008, 121 ( 1 ) : 89-96.
  • 5常立文.新生儿支气管肺发育不良诊治进展[J].临床儿科杂志,2007,25(3):161-165. 被引量:46
  • 6Hernandez-Ronquillo L, Tellez-Zenteno JF, Weder- Cisneros N, et al. Risk factors for the development of bronchopulmonary dysplasia: a case-control study [J]. Arch Med Res, 2004,35 (6) : 549-553.
  • 7朱雪萍,肖志辉,丁晓春,冯星.早产儿支气管肺发育不良的高危因素及预防对策[J].中国实用儿科杂志,2007,22(9):663-665. 被引量:12
  • 8Cunha GS, Mezzacappa-Filho F, Ribeiro JD. Risk factors for bronchopulmonary dysplasia in very low birth weight newborns treated with mechanical ventilation in the first week of life [J]. J Trop Pediatr,2005,51 (6) :334-340.
  • 9Kinsella JP, Greenough A, Abman SH. Bronchopulmonary dysplasia [J]. Lancet,2006,367(9520) : 1421-1431.
  • 10Jobe AH. Postnatal corticosteroids for preterm infants- do what we say, not what we do [J]. New Engl J Med, 2004, 350(13) :1349-1351.

二级参考文献32

  • 1Taeusch HW,Ballard RA,Gleason CA.Avery's diseases of the newborn[M].8th ed.Philadelphia:Elsevier Saunders,2004:723-736.
  • 2Jobe AH,Bancalari E.Bronchopulmonary dysplasia[J].Am J Respir Crit Care Med,2001,163 (7):1723-1729.
  • 3Monte LF,Silva Filho LV,Miyoshi MH,et al.Bronchopulmonary dysplasia[J].J Pediatr,2005,81 (2):99-110.
  • 4Banks-Randall BA,Ballard RA.Bronchopulmonary dysplasia[M]//Taeusch HW,Ballard RA,Gleason CA.Avery's diseases of the newborn.8th ed.Philadelphia:W.B.Saunders,2005:723-733.
  • 5Makri V,Hospes B,Stoll-Becker S,et al.Polymorphisms of surfactant protein B encoding gene:modifiers of the course of neonatal respiratory distress syndrome[J].Eur J Pediatr,2002,161 (11):604-608.
  • 6Hallman M,Haataja R.Genetic influences and neonatal lung disease[J].SeminNeonatol,2003,8 (1):19-27.
  • 7Saugstad OD.Bronchopulmonary dysplasia-oxidative stress and antioxidants[J].Semin Neonatol,2003,8 (1):39-49.
  • 8Lyon A.Chronic lung disease of prematurity.The role of intrauterine infection[J].Eur J Pediatr,2000,159(11):798-802.
  • 9Hernandez-Ronquillo L,Tellez-Zenteno JF,Weder-Cisneros N,et al.Risk factors for the development of bronchopulmonary dysplasia:a case-control study[J].Arch Med Res,2004,35 (6):549-553.
  • 10Aukland SM,Halvorsen T,Fosse KR,et al.High-resolution CT of the chest in children and young adults who were born prematurely:findings in a population-based study[J].AJR Am J Roentgenol,2006,187 (4):1012-1018.

共引文献54

同被引文献63

  • 1邓睿,唐彬秩,刘华,屈艺,母得志.新生儿肺透明膜病发病及预后的高危因素分析[J].四川大学学报(医学版),2010,41(4):688-691. 被引量:16
  • 2刘艳,朱铭.儿童胸部影像学诊断 第5讲 新生儿肺部影像诊断[J].中国实用儿科杂志,2004,19(7):446-447. 被引量:8
  • 3陈幽,叶贞志,卢光进.极低出生体质量儿并支气管肺发育不良的危险因素[J].实用儿科临床杂志,2007,22(2):109-110. 被引量:5
  • 4常立文.新生儿支气管肺发育不良诊治进展[J].临床儿科杂志,2007,25(3):161-165. 被引量:46
  • 5邵肖梅,叶鸿瑁,丘小汕.实用新生儿学[M].第4版.北京:人民卫生出版社,2011:872.
  • 6Hausding M, Tepe M, Ubel C et al. Induction of tolerogenic lung CD4 + T cells by local treatment with a pSTAT- 3 and pSTAT4 inhibitor ameliorated experimental allergic asthma [J].Intlmmunol, 2011, 23 (1): 1.
  • 7Knight D, Mutsaers SE, Prele CM. STAT3 in tissue fibrosis: is there a role in the lung [J]. Pulm Pharmacol Ther, 2011, 24 (2): 193.
  • 8Zhao W, Jaganathan S, Turkson J. A cell - permeable STAT3 SH2 domain mimetic inhibits STA33 activation and induces an- titumor cell effects in vitro[J]. J Biol Chem, 2010, 285 (46) : 35855.
  • 9Chiba Y, Todoroki M, Misawa M. Antigen exposure causes activations of signal transducer and activator of transcription 6 (STAT6) and STATI, but not STAT3, in lungs of sensitized mice [J].Immunopharmacol lmmunotoxicol, 2011, 33 (1): 43.
  • 10Northway WJ, Rosan RC, Porter DY. Pulmonary disease follow- ing respirator therapy of hyaline-membrane disease: Bronehopul- monary dysplasia. N Engl J Med, 1967,276(7) : 357-368.

引证文献10

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部